Transactions under Novozymes’ stock buyback program

As of July 10, Novozymes has purchased an accumulated 3,757,683 shares with a transaction value of DKK 956.7 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2014.

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:       

 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
3,495,924
 
884,887,443
July 4, 2014
40,000
278.86
11,154,572
July 7, 2014
30,482
 276.39
8,425,041
July 8, 2014
44,662
275.15
12,288,645
July 9, 2014
77,482
 272.95
21,148,349
July 10, 2014
69,133
271.27
18,753,633
Total accumulated under the program
3,757,683
 
956,657,683

In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 4,625 B shares in the period from July 4 to July 10, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
 
Following the transactions stated above, Novozymes owns a total of 7,890,199 treasury shares, corresponding to 2.5% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.
 
Contact information
Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339